NEU 0.00% $19.97 neuren pharmaceuticals limited

Ann: Trading Halt, page-141

  1. 454 Posts.
    lightbulb Created with Sketch. 50
    What is your logic? SP was at $25 in December after positive results on one indication. Successful P2 for a 2nd indication surely adds to coy's valuation and statistically enhances likelihood of success in the remaining twoth trials. One would think solid results on Monday should take SP through $30 especially with a third readout in a couple of months.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.